All Stories

  1. RF26 | PMON334 Once-Weekly Somapacitan in Growth Hormone Deficiency: 4-Year Efficacy and Safety Results from REAL 3, a Randomised Controlled Phase 2 Trial
  2. Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia
  3. Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
  4. Association of childhood growth hormone treatment with long-term cardiovascular morbidity
  5. Long-term safety of growth hormone treatment in childhood: two Large observational studies: nordiNet IOS and ANSWER
  6. Growth Hormone Use in Childhood and Adult Cardiovascular Disease—Reply
  7. Once-weekly somapacitan vs daily GH in children with GH deficiency: results from a randomized phase 2 trial
  8. Childhood Growth Hormone Treatment and Long-Term Cardiovascular Morbidity
  9. Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment
  10. SUN-247 Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Efficacy and Safety Results of a Randomized, Open-Label, Controlled Phase 2 Trial (REAL 3)
  11. Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid‐induced bone growth impairment
  12. Tall Stature
  13. Final results of NordiNet® international outcome study: key outcomes
  14. Animal models to explore the effects of glucocorticoids on skeletal growth and structure
  15. Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study
  16. The Physiology of Childhood Growth: Hormonal Regulation
  17. Venetoclax in cancer therapy and potential effects on bone
  18. Is safety of childhood growth hormone therapy related to dose? Data from a large observational study
  19. The Evaluation and Management of Tall Stature
  20. RECENT RESEARCH ON THE GROWTH PLATE: Impact of inflammatory cytokines on longitudinal bone growth
  21. Mutations inSLC34A3/NPT2cAre Associated with Kidney Stones and Nephrocalcinosis
  22. Protective Role of Humanin on Bortezomib-Induced Bone Growth Impairment in Anticancer Treatment
  23. Dexamethasone differentially regulates Bcl-2 family proteins in human proliferative chondrocytes: Role of pro-apoptotic Bid
  24. Bortezomib treatment causes long-term testicular dysfunction in young male mice
  25. Risks of Malignant and Non-Malignant Tumours in Tall Women Treated with High-Dose Oestrogen during Adolescence
  26. Common DNA variants predict tall stature in Europeans
  27. Interleukin-6 acts locally on the growth plate to impair bone growth
  28. Resveratrol Treatment Delays Growth Plate Fusion and Improves Bone Growth in Female Rabbits
  29. The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of ...
  30. Bortezomib and bone health in adults: can we extend these findings to children?
  31. Vitamin D Levels in Children Born to Vitamin D-Deficient Mothers
  32. Bortezomib Is Cytotoxic to the Human Growth Plate and Permanently Impairs Bone Growth in Young Mice
  33. Identification of a clonally expanding haematopoietic compartment in bone marrow
  34. The Effect of Acute and Chronic Stress on Growth
  35. OR11-6 Long-term mortality in patients with isolated GHD, ISS, and SGA treated with recombinant GH during childhood in Sweden: Application of a mortality model developed from the general population
  36. Comparison of response to 2-years’ growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large observa...
  37. Inhibition of autophagy promotes chondrocyte differentiation and stimulates longitudinal bone growth
  38. The role of estrogen receptor-αlpha and its activation function 1 (af-1) for growth plate closure in female mice
  39. Ablation of the Pro-Apoptotic Protein Bax Protects Mice from Glucocorticoid-Induced Bone Growth Impairment
  40. The role of estrogen receptor-  and its activation function-1 for growth plate closure in female mice
  41. Long-Term Mortality and Causes of Death in Isolated GHD, ISS, and SGA Patients Treated with Recombinant Growth Hormone during Childhood in Belgium, The Netherlands, and Sweden: Preliminary Report of 3 Countries Participating in the EU SAGhE Study
  42. Genetic Regulation of the Growth Plate
  43. Gender Influences Short-Term Growth Hormone Treatment Response in Children
  44. Pro-Inflammatory Cytokines Produced by Growth Plate Chondrocytes May Act Locally to Modulate Longitudinal Bone Growth
  45. Double-Edged Sword of Novel Anti-Cancer Treatment: Proteasome Inhibition in the Growth Plate Causes Impairment of Longitudinal Bone Growth
  46. Insulin-like growth factor-1 restores dexamethasone-induced heart growth arrest in rats: the role of the ubiquitin pathway
  47. Vitamin D deficiency during pregnancy-potential threat to the child
  48. Mechanisms of Growth Plate Maturation and Epiphyseal Fusion
  49. Estrogen Signaling in Growth Plate Cartilage
  50. The Biologics Anakinra and Etanercept Prevent Cytokine-Induced Growth Retardation in Cultured Fetal Rat Metatarsal Bones
  51. Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients
  52. The Use of Bone Age in Clinical Practice – Part 1
  53. Validation and Reference Values of Automated Bone Age Determination for Four Ethnicities
  54. The role of estrogen receptor α in growth plate cartilage for longitudinal bone growth
  55. Expression of vascular endothelial growth factor in the growth plate is stimulated by estradiol and increases during pubertal development
  56. Bone, Growth Plate and Mineral Metabolism
  57. Hormones and Genes of Importance in Bone Physiology and Their Influence on Bone Mineralization and Growth in Turner Syndrome
  58. Efficacy and Safety of Percutaneous Epiphysiodesis Operation around the Knee to Reduce Adult Height in Extremely Tall Adolescent Girls and Boys
  59. Efficacy and Safety of Percutaneous Epiphysiodesis Operation around the Knee to Reduce Adult Height in Extremely Tall Adolescent Girls and Boys
  60. P31 Earlier start of puberty in GH treated children born SGA than in GH treated for GHD. Data from the NordiNet® IOS
  61. Epiphyseal Fusion in the Human Growth Plate Does not Involve Classical Apoptosis
  62. Proinsulin C-peptide Regulates Ribosomal RNA Expression
  63. Catch-up growth after dexamethasone withdrawal occurs in cultured postnatal rat metatarsal bones
  64. Promoting Growth in Chronic Inflammatory Disease: Lessons from Studies of the Growth Plate
  65. The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice
  66. P-44 Gender related IGF-I changes after two years of growth hormone (GH) treatment in GH deficient (GHD) children and adults. Data from the NordiNet® International Outcome Study (IOS)
  67. The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone
  68. Effects of alendronate and pamidronate on cultured rat metatarsal bones: Failure to prevent dexamethasone-induced growth retardation
  69. Tamoxifen Impairs Both Longitudinal and Cortical Bone Growth in Young Male Rats
  70. The 7th ESPE Growth Plate Working Group Symposium - EUROGROP, June 27th 2007, Helsinki, Finland
  71. Intramuscular Autotransplantation of Pancreatic Islets in a 7-Year-Old Child: A 2-Year Follow-Up
  72. GPR30 Estrogen Receptor Expression in the Growth Plate Declines as Puberty Progresses
  73. Proteasome inhibition therapies in childhood cancer
  74. Proteasome Inhibition Up-regulates p53 and Apoptosis-Inducing Factor in Chondrocytes Causing Severe Growth Retardation in Mice
  75. Oestrogen receptors and linear bone growth
  76. Tamoxifen induces permanent growth arrest through selective induction of apoptosis in growth plate chondrocytes in cultured rat metatarsal bones
  77. Glucocorticoid eye drops inhibit growth in the newborn rabbit
  78. P-93 NordiNet®: FROM PATIENT MANAGEMENT TO OUTCOME RESEARCH TOOL
  79. OR10-3 BASELINE CHARACTERISTICS AND TREATMENT RESPONSE TO GH IN GH-DEFICIENT CHILDREN REPORTED TO THE NordiNet® OUTCOME DATABASE
  80. Metacarpophalangeal pattern profile analysis: useful diagnostic tool for differentiating between dyschondrosteosis, turner syndrome, and hypochondroplasia
  81. Growth Plate and Cellular Growth
  82. The Fifth European Growth Plate Working Group Symposium
  83. Glucocorticoid eye drops inhibit growth in the newborn rabbit
  84. Metacarpophalangeal pattern profile analysis as a tool for early diagnosis of turner syndrome
  85. Dexamethasone Induces Apoptosis in Proliferative Chondrocytes through Activation of Caspases and Suppression of the Akt-Phosphatidylinositol 3′-Kinase Signaling Pathway
  86. Growth Plate and Cellular Growth
  87. The 4t h European Growth Plate Working Group Symposium (EUROGROP)
  88. Hormonal Regulation of Growth Plate Cartilage
  89. Additive Protective Effects of Estrogen and Androgen Treatment on Trabecular Bone in Ovariectomized Rats
  90. Interleukin-1β and TNF-α Act in Synergy to Inhibit Longitudinal Growth in Fetal Rat Metatarsal Bones
  91. Estrogen Receptor-β Inhibits Skeletal Growth and Has the Capacity to Mediate Growth Plate Fusion in Female Mice
  92. Raloxifene Acts as an Estrogen Agonist on the Rabbit Growth Plate
  93. Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes
  94. Expression and localization of Indian hedgehog (Ihh) and parathyroid hormone related protein (PTHrP) in the human growth plate during pubertal development
  95. Estrogen receptor-alpha and -beta are expressed throughout postnatal development in the rat and rabbit growth plate
  96. Apoptosis Is Developmentally Regulated in Rat Growth Plate
  97. Estrogens and human growth
  98. Delayed diagnoses of Turner’s syndrome: Proposed guidelines for change
  99. Turner syndrome: a pattern of early growth failure
  100. Disproportional Body Growth in Female Estrogen Receptor-α-Inactivated Mice
  101. Demonstration of Estrogen Receptor-β Immunoreactivity in Human Growth Plate Cartilage
  102. Prolonged fasting in humans results in diminished plasma choline concentrations but does not cause liver dysfunction
  103. Decreased Interleukin-2 Production from Cultured Peripheral Blood Mononuclear Cells in Human Acute Starvation
  104. Decreased Interleukin-2 Production from Cultured Peripheral Blood Mononuclear Cells in Human Acute Starvation1
  105. Fasting Prevents Experimental Murine Colitis Produced by Dextran Sulfate Sodium and Decreases Interleukin-1  and Insulin-Like Growth Factor I Messenger Ribonucleic Acid
  106. Fasting Prevents Experimental Murine Colitis Produced by Dextran Sulfate Sodium and Decreases Interleukin-1β and Insulin-Like Growth Factor I Messenger Ribonucleic Acid1
  107. Enrichment of type I and type II rat somatotrophs: characterization of growth hormone secretion in vitro.
  108. Cell volume and shape oscillations in rat type-II somatotrophs at hypotonic conditions
  109. Effects of galanin on growth hormone release in isolated cultured rat somatotrophs
  110. LOW PROCONVERTIN (FACTOR VII) AND IMPAIRED BLOOD CLOTTING DUE TO GROWTH HORMONE DEFICIENCY IN THE RAT
  111. Effect of N-methyl-D,L-aspartate on isolated rat somatotrophs.
  112. Acute and long-term biphasic volume alterations in rat type-II somatotrophs during GH secretory stimulation
  113. Morphology and Filterability of Red Blood Cells in Neonatal and Adult Rats
  114. The Correlation between Calcium Outflow and Growth Hormone Release in Perifused Rat Somatotrophs*
  115. Perchlorate stimulates potassium-induced growth hormone release in cultured rat somatotrophs
  116. Growth hormone-releasing factor induces a biphasic modulation of K+permeability in perfused cultured rat somatotrophs
  117. An ultrastructural and functional characterization of rat somatotrophs highly enriched on a continuous Percoll density gradient
  118. Endogenous testosterone enhances growth hormone (GH)-releasing factor-induced GH secretion in vitro
  119. Effects of 5-Hydroxytryptamine, Dopamine, and Aromatic L-Amino Acids on Growth Hormone (GH) -Releasing Factor-Stimulated GH Release in Rat Anterior Pituitaries*